Showing results (381-390 of 858) with videos related to

Sort By:
Pageof 86
Life (Basel, Switzerland)|October 28, 2023
The CHA2DS2-VASC Score Predicts Mortality in Patients Undergoing Coronary AngiographyNicholay Teodorovich, Gera Gandelman, Michael Jonas, et al.
Journal of Hepatology|October 26, 2011
Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysisHelen M Parker, Nathan A Johnson, Catriona A Burdon, et al.
ACS Applied Bio Materials|October 8, 2024
Bioinspired Hydrophobicity via Temperature-Induced Phase Separation of Beeswax: A Pathway for Developing Cellulose Nanofiber-Based Adsorbents for the Removal of Conventional Tetracycline TabletsAjith Mathew, Aiswarya Poulose, Sari Panikkassery Sasidharan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 25, 2006
Renal involvement in multicentric Castleman disease with glomeruloid hemangioma of skin and plasmacytomaSusan Uthup, Krishna Balachandran, Vimala Avadai Ammal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2007
Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosisAdi Mor, David Planer, Galia Luboshits, et al.
Microvascular Research|March 28, 2009
Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout miceArnon Afek, Evgeny Kogan, Sofia Maysel-Auslender, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 14, 2014
Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic functionKaren Louise Thomsen, Henning Grønbæk, Emilie Glavind, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 3, 2015
The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertensionHien T T Duong, Zhixia Dong, Lin Su, et al.
Alimentary Pharmacology & Therapeutics|June 24, 2021
Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertensionNikolaj Rittig, Niels Kristian Aagaard, Gerda Elisabeth Villadsen, et al.
Atherosclerosis|May 12, 2004
L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplastyJacob George, Sigal Ben Shmuel, Arie Roth, et al.
Pageof 86